Besançon residents have a simple, yet potentially life-saving, tool available to them in the fight against colorectal cancer. A home-based screening test, free of charge, allows individuals to proactively check for early signs of the disease. This initiative, spearheaded by the Institut Régional Fédératif du Cancer de Franche-Comté (IRFC), aims to increase participation in crucial preventative healthcare, particularly as colorectal cancer remains a significant public health concern in France.
Colorectal cancer, affecting both the colon and the rectum, is one of the most commonly diagnosed cancers in the country. According to figures from the Institut National du Cancer, in 2022, over 47,500 people were diagnosed with the disease, resulting in nearly 17,000 deaths. Early detection is key; in approximately 80% of cases, the cancer develops from a slowly evolving, initially benign tumor. This underscores the importance of regular screening to identify and address these potentially cancerous growths before they progress.
Understanding the Scope of the Problem
In 2023 alone, 26,212 men and 21,370 women in France received a diagnosis of colorectal cancer, with median ages of 71 and 72 respectively. Sadly, men are disproportionately affected by fatal cases, accounting for 8,977 of the 17,000 deaths, compared to 7,998 women. Still, there is encouraging news: mortality rates have seen a modest decline of 2% among men and 1.5% among women between 2012 and 2022. This improvement is largely attributed to increased access to colorectal cancer screening and the removal of precancerous lesions.
Statistically, colorectal cancer ranks as the third most frequent cancer diagnosed in men, following prostate and lung cancer, representing 11.2% of all new male cancer cases. For women, We see the second most common cancer after breast cancer, accounting for 11.3% of new diagnoses. It remains the second leading cause of cancer-related deaths in France, particularly among individuals aged 65 and older. Despite these sobering statistics, the long-term trend shows a consistent decrease in mortality rates since 1980, directly linked to improved screening programs and surgical interventions.
The Power of Early Detection
The recommended screening guidelines target individuals aged 50 to 74. Those within this age range are invited to participate in an immunological test every two years. This involves a simple at-home test requiring a stool sample. The test kits are readily available free of charge from a primary care physician, a pharmacist, or a gastroenterologist, and can also be ordered online.
Despite the accessibility and proven benefits of this screening method, participation rates remain concerningly low, with only one in three eligible individuals taking advantage of the opportunity. To address this, the gastroenterology teams at the CHU Besançon Franche-Comté have launched a proactive outreach program called “Mardis Bleus” (Blue Tuesdays) throughout March.
Bringing Screening to the Community
The “Mardis Bleus” initiative involves mobile screening stations set up at various locations throughout the Besançon area. Following a visit to Super U de l’Amitié on March 10th, teams will be present at the Carrefour in Chalezeule on March 24th (9:00 AM to 1:00 PM) and at the Galerie Châteaufarine on March 31st (9:00 AM to 1:00 PM). These events provide a valuable opportunity for community members to speak directly with healthcare professionals and receive accurate information about colorectal cancer screening.
Adding an artistic dimension to the campaign, the Pierre Fabre laboratories have partnered with the CHU Besançon Franche-Comté to feature the work of artist Jordane Saget. Saget has created a striking mural composed of “lines of life” which is currently on display in the lobby of the Jean Minjoz hospital, serving as a visual reminder of the importance of preventative health measures.
What the Experts Say
Yves Quemeneur, a key figure in the initiative, emphasizes the importance of overcoming the stigma surrounding colorectal cancer and promoting widespread participation in screening programs. Even as a direct quote from Quemeneur was not available in the source material, the IRFC’s campaign underscores a commitment to direct and impactful communication to raise awareness.
Colorectal cancer screening isn’t just about detecting cancer; it’s about preventing it. By identifying and removing precancerous polyps during a colonoscopy – often recommended after a positive stool test – doctors can stop cancer from developing in the first place. This proactive approach is a cornerstone of modern cancer care.
If you are between the ages of 50 and 74, please discuss colorectal cancer screening with your doctor. Early detection significantly increases the chances of successful treatment and a full recovery. You can find more information about colorectal cancer and screening options from the Institut National du Cancer.
The CHU Besançon Franche-Comté will continue its outreach efforts, and residents can expect further updates on screening initiatives. The success of this program hinges on community engagement and a collective commitment to prioritizing preventative healthcare. Share this information with your loved ones and encourage them to take proactive steps to protect their health.
Keep reading
